Avinger, Inc. (AVGR)

NASDAQ: AVGR · IEX Real-Time Price · USD
1.74
-0.10 (-5.38%)
Aug 16, 2022 11:19 AM EDT - Market open
-5.38%
Market Cap 12.26M
Revenue (ttm) 8.79M
Net Income (ttm) -28.71M
Shares Out 7.04M
EPS (ttm) -5.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 127,074
Open 1.81
Previous Close 1.84
Day's Range 1.74 - 1.89
52-Week Range 1.40 - 19.26
Beta 1.67
Analysts Buy
Price Target 7.65 (+339.4%)
Earnings Date Aug 11, 2022

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as w... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jan 30, 2015
CEO Jeffrey Soinski
Employees 68
Stock Exchange NASDAQ
Ticker Symbol AVGR
Full Company Profile

Financial Performance

In 2021, Avinger's revenue was $10.13 million, an increase of 15.63% compared to the previous year's $8.76 million. Losses were -$17.41 million, -8.39% less than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for AVGR stock is "Buy." The 12-month stock price forecast is 7.65, which is an increase of 339.40% from the latest price.

Price Target
$7.65
(339.40% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Avinger Reports Second Quarter 2022 Results

REDWOOD CITY, CA / ACCESSWIRE / August 11, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-...

Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market ...

REDWOOD CITY, CA / ACCESSWIRE / August 8, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company developing and marketing the first and only intravascular image-gu...

Avinger to Announce Second Quarter 2022 Results on August 11

REDWOOD CITY, CA / ACCESSWIRE / August 5, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules

REDWOOD CITY, CA / ACCESSWIRE / August 4, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...

Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System

REDWOOD CITY, CA / ACCESSWIRE / July 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

Avinger Expands International Presence with First Commercial Shipment to Chile

REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022

REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

REDWOOD CITY, CA / ACCESSWIRE / June 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

Avinger (AVGR) Reports Q1 Loss, Misses Revenue Estimates

Avinger (AVGR) delivered earnings and revenue surprises of -92.56% and 0.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Avinger Reports First Quarter 2022 Results

REDWOOD CITY, CA / ACCESSWIRE / May 10, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-bas...

Avinger to Announce First Quarter 2022 Results on May 10

REDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

Avinger Announces Full Commercial Launch of Lightbox 3

REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...

Avinger Announces Issuance of Three New U.S. Patents in March 2022

16 New U.S. and International Patents Issued over Past Year REDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketi...

Avinger Regains Compliance with Nasdaq Listing Requirements

REDWOOD CITY, CA / ACCESSWIRE / March 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

Avinger (AVGR) Reports Q4 Loss, Tops Revenue Estimates

Avinger (AVGR) delivered earnings and revenue surprises of 0% and 4.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Avinger Registers 12% Decline In Q4 Revenue, Says Hospital Constraints Impacted Q4

Avinger Inc (NASDAQ: AVGR) reported a fourth-quarter revenue decrease of 12% year-over-year to $2.40 million, beating the consensus of $2.29 million. Hospital constraints impacted Q4 on procedural volum...

Avinger Reports Fourth Quarter and Year End 2021 Results

REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-b...

Avinger to Announce Full-Year 2021 Results on March 22

REDWOOD CITY, CA / ACCESSWIRE / March 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

Avinger to Effect One-for-Twenty Reverse Stock Split

REDWOOD CITY, CA / ACCESSWIRE / March 14, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

Avinger Expands Lightbox 3 First Case Experience

Patients Treated in Four Additional Hospitals Using New Portable System REDWOOD CITY, CA / ACCESSWIRE / March 7, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing t...

Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console

REDWOOD CITY, CA / ACCESSWIRE / February 28, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...

Avinger Announces Closing of $7.6 Million Registered Direct Offering

REDWOOD CITY, CA / ACCESSWIRE / January 14, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided, cathete...

Avinger Announces $7.6 Million Registered Direct Offering

REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided, cathete...

Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console

REDWOOD CITY, CA / ACCESSWIRE / January 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f...